Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

Overview of attention for article published in BMC Cancer, March 2007

Altmetric Badge

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 56 Mendeley

Summary Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experience

Article in Current Cancer Drug Targets (January 2024)

Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study

Article in National Medical Journal of China (August 2020)

Chapter 4 HER2-Positive Breast Cancer Second Line and Beyond

Book chapter (January 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.